Canada tells drug sponsors how to submit risk management plans in EU/US formats
This article was originally published in SRA
Health Canada has issued final guidance explaining the steps that drug sponsors should follow when submitting a Canadian risk management plan in the European or other recognized formats1. The guidance also explains how sponsors should follow-up on RMP commitments and submit updates on this front.
Register for our free email digests: